FCFR2 EXON IIIA AND IIIE MUTATIONS IN CROUZON, JACKSON-WEISS, AND PFEIFFER SYNDROMES - EVIDENCE FOR MISSENSE CHANGES, INSERTIONS, AND A DELETION DUE TO ALTERNATIVE RNA SPLICING
Ga. Meyers et al., FCFR2 EXON IIIA AND IIIE MUTATIONS IN CROUZON, JACKSON-WEISS, AND PFEIFFER SYNDROMES - EVIDENCE FOR MISSENSE CHANGES, INSERTIONS, AND A DELETION DUE TO ALTERNATIVE RNA SPLICING, American journal of human genetics, 58(3), 1996, pp. 491-498
Fibroblast growth factor receptor 2 (FGFR2) mutations have been associ
ated with the craniosynostotic conditions Crouzon, Jackson-Weiss, and
Pfeiffer syndromes. Previously, mutations were described in the exons
IIIa and IIIc, which form the extracellular, third immunoglobulin-like
domain (IgIII) and adjacent linker regions, both of which are normall
y involved in ligand binding;. For all three conditions, mutations wer
e found in exon IIIc. Only in Crouzon syndrome were mutations identifi
ed in exon IIIa. In this study, 39 cases with one of these three condi
tions were screened for exon IIIa or IIIc mutations. Eleven mutations
are reported in 17 unrelated cases. Mutations in exon IIIa are identif
ied for not only Crouzon but also Jackson-Weiss and Pfeiffer syndromes
. Four mutations in either exon IIIa or exon IIIc reported only in Cro
uzon syndrome are present also in one of the other two syndromes. Two
insertions, one in exon IIIa in a Crouzon syndrome patient and the oth
er in exon IIIc in a Pfeiffer syndrome patient, were observed. The lat
ter mutation has the same alternative RNA splicing effect as a reporte
d synonymous mutation for Crouzon syndrome. A missense mutation was de
tected in one Pfeiffer syndrome family in which two members had cranio
synostosis without limb anomalies. The inter- and intrafamilial variab
ility in expression of FGFR2 mutations suggests that these three syndr
omes, presumed to be clinically distinct, are instead representative o
f a spectrum of related craniosynostotic and digital disorders.